Skip to main content

SHINE Medical eyeing Mo-99 production facility in Europe

When the European facility begins production, SHINE will be capable of producing more than two-thirds of the global patient demand for Mo-99, the company recently stated.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.